T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients (Tcell-Brazil)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03207789|
Recruitment Status : Enrolling by invitation
First Posted : July 5, 2017
Last Update Posted : July 5, 2017
The designed study follows up on the previous one by the international T-cell project (Bellei et al,, 2012) and its purpose is to verify whether a prospective collection of data would permit access to more accurate information permitting a better definition of prognosis and investigation of more adequate treatment strategies for these neoplasms.
The analysis of patients distributed in all five macro regions of the country and a comparison among them will provide a real picture of the disease in Brazil, limiting the bias probably found in the previous projects.
|Condition or disease|
|T-cell Lymphoma NK-Cell Lymphoma T-cell Lymphoma Adults|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||500 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Prospective Collection of Data in Patients With T-cell Lymphomas Distributed in the Five Distinct Macro Regions of Brazil|
|Actual Study Start Date :||January 1, 2015|
|Actual Primary Completion Date :||June 1, 2017|
|Estimated Study Completion Date :||December 31, 2020|
- Descriptive analysis during the first year of T-cell Brazil Registry [ Time Frame: 12 months of registring ]Descriptive analysis and Overall survival
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03207789
|Study Chair:||Eliana CM Miranda, M.Ed.; Ph.D.||Grupo de Estudos Multicentricos em Onco-Hematologia|